Baidu
map

JNNP:华山医院郁金泰教授牵头制定阿尔茨海默病循证预防国际指南

2020-08-26 复旦上海医学院 复旦上海医学院 发表于威斯康星

《世界阿尔茨海默病2018年报告》显示,每3秒钟,全球就有一名痴呆症患者产生。目前,全球至少有5000万的痴呆患者,预计到2050年,这个数字将达到1.52亿,其中约60-70%为阿尔茨海默病(Alz

《世界阿尔茨海默病2018年报告》显示,每3秒钟,全球就有一名痴呆症患者产生。目前,全球至少有5000万的痴呆患者,预计到2050年,这个数字将达到1.52亿,其中约60-70%为阿尔茨海默病(Alzheimer's disease, AD)患者。在中国,目前约有1000万AD患者,预计到2050年,我国AD患者将超过4000万人。这已成为严重影响全球人口健康和生活质量的重大公共健康问题。

目前尚无特效疗法能阻止或逆转AD的病情进展,但越来越多的流行病学研究表明,AD是可以预防的,有效控制危险因素、合理利用保护因素可以显著降低AD的发病率和患病率。遗憾的是,目前尚无针对这一严重威胁人类健康脑重大疾病的国际循证医学证据来指导临床实践。针对这一迫切需求,复旦大学附属华山医院神经内科郁金泰教授临床研究团队联合国际老年学会主席Bruno Vellas院士、美国南加州大学Paul S Aisen教授和哈佛医学院Can Zhang教授、加拿大麦吉尔大学Serge Gauthier教授、英国剑桥大学John Suckling教授、法国蒙彼利埃大学Jacques Touchon教授和图卢兹第三大学Sandrine Andrieu教授、新加坡国立大学Ee-Heok Kua教授和Lei Feng教授、希腊约阿尼纳大学Evangelos Evangelou教授、香港中文大学Vincent Mok教授和首都医科大学宣武医院贾建平教授、第三军医大学大坪医院王延江教授、华中科技大学同济医院潘安教授、青岛大学青岛市立医院谭兰教授、复旦大学附属华山医院董强教授等该领域国内外知名学者,对现有的研究证据进行了系统回顾和荟萃分析,制定了全球首个AD循证预防国际指南,该指南对于AD预防策略的制定有重大意义,相关研究成果近日以“阿尔茨海默病循证预防(Evidence-based prevention of Alzheimer's disease)”为题,发表于本领域国际顶尖杂志《英国医学杂志》(The British Medical Journal, BMJ)的子刊《神经学,神经外科学与精神病学杂志》(Journal of Neurology, Neurosurgery & Psychiatry, JNNP)上,并被BMJ出版社选为媒体发布,向全球5000家国际媒体发布此项研究结果,引起了国际医学界的广泛关注。

本项研究历时五年余,从44676项研究中选择纳入符合标准的243个观察性前瞻性研究(OPSs)和153个随机对照试验(RCTs),对104个可干预影响因素和11项干预措施进行系统研究和荟萃分析,并且依据推荐分级的评估、制定与评价(GRADE)标准制定了循证医学的证据级别和推荐等级:证据级别分为A级证据> B级证据> C级证据;相关干预的推荐等级分为: I级推荐(强烈推荐), II 级推荐(弱推荐) 和III级推荐(不推荐)。最终根据循证医学标准,制定了AD的预防指南,形成了21条推荐意见(见表1)。

表1 阿尔茨海默病预防指南: 初步临床推荐*

*对于某些影响因素,无法给出太详尽的建议(尤其是具体的剂量和疗程),未来需要设计良好的试验来重复验证(关键研究)。此外,这些建议的提出无法避免现有研究的局限性及后续研究的不可预知性。

#在随机对照试验中,某些干预措施如体育锻炼无法实现绝对盲法或分配隐藏,不可避免地造成高偏倚风险。因此,我们认为有统计学意义的结果比风险级别更可靠一些。

郁金泰教授牵头的国际研究团队针对19个影响因素/干预措施提出I级推荐建议,其中10个影响因素/干预措施具有A级证据水平,包括:①65岁以上人群应保持体重指数在一定范围内,不宜太瘦;②多从事认知活动,如阅读、下棋等刺激性脑力活动;③保持健康的生活方式,避免罹患糖尿病,对于糖尿病患者应密切监测其认知功能减退情况;④保护头部,避免外伤;⑤65岁以下人群应保持健康的生活方式,避免罹患高血压;⑥避免直立性低血压发生,对于直立性低血压患者,应密切监测其认知功能状态;⑦保持良好的心理健康状态,对于已有抑郁症状的患者,应密切监测其认知功能状态;⑧放松心情,平时避免过度紧张;⑨早年应尽可能多地接受教育;⑩定期检测血同型半胱氨酸水平,对于高同型半胱氨酸血症患者应用维生素B和/或叶酸治疗,同时密切监测其认知功能状态(该项干预措施结论与其他研究结果一致,目前降同型半胱氨酸治疗被认为是最有希望的AD预防措施)。其余9个影响因素/干预措施具有B级证据水平,包括:①65岁以下人群应减轻体重,BMI保持在18.5-24.9 kg/m2范围内最佳;②65岁以上人群应警惕体重减轻,若出现BMI下降趋势,应密切监测其认知功能状态;③坚持定期体育锻炼;④不要吸烟,同时也要避免接触环境中的烟草烟雾,对于吸烟人群应尽快采取各种方式戒烟;⑤保证充足良好的睡眠,出现睡眠障碍时要及时诊治;⑥保持健康的生活方式、合理用药,避免罹患脑血管疾病,对于卒中患者,尤其是脑微出血患者,应密切监测其认知功能改变,并采取有效的预防措施保护其认知功能;⑦晚年保持健康强壮的体魄,对于越来越虚弱的人群,应密切监测其认知功能状态;⑧维持心血管系统良好状态,对于房颤患者应用药物治疗;⑨饮食摄入或额外补充维生素C。以上这些建议近三分之二与心血管病危险因素和生活方式密切相关,可见保持良好的心脑血管状态和健康的生活方式对预防AD的重要性。

此外,该研究指出,有2项干预措施并不推荐(III级推荐)用于AD的预防:雌激素替代疗法(A2级证据)和乙酰胆碱酯酶抑制剂(B级证据)。

该研究还将以上I级推荐的19个影响因素/干预措施在人体生命周期中的分布年龄段进行了系统的分类(见图1)。

对于幼年(<5岁)人群,可干预的影响因素研究甚少,相关数据及结论较少;

对于青少年(6-15岁)人群,为预防AD,应尽可能多地接受教育;

对于中青年(15-65岁)人群,为预防AD,应避免的危险因素有肥胖、吸烟、睡眠障碍、糖尿病、脑血管疾病(脑微出血、颈总动脉内膜增厚、卒中等)、高血压、抑郁、精神紧张,应实现的保护因素有体育锻炼、减轻体重、维生素C摄入、健康的生活方式;

对于老年(>65岁)人群,为预防AD,应避免的危险因素有体重减轻、吸烟、睡眠障碍、糖尿病、脑血管疾病(脑微出血、颈总动脉内膜增厚、卒中等)、头部外伤、体弱、直立性低血压、抑郁、心房颤动、高同型半胱氨酸血症,应实现的保护因素有维持体重指数不要太瘦、体育锻炼、认知活动、维生素C摄入、健康的生活方式。

图1:x轴表示包括观察性前瞻性研究在内的总样本的平均年龄(实心圆)和平均年龄范围(短水平线);y轴表示相对危险度(RR);OH-直立性低血压,CVD-脑血管疾病,IMT-血管内膜厚度。

郁金泰教授提出,以上多个基于循证的临床建议的联合应用可能是预防AD的最佳选择,未来应开展真实世界大样本研究,致力于探寻I级推荐A级证据的多项建议的最优化组合,着重关注尚未发病但具有痴呆高风险的人群(如AOPEε4携带者、多基因评分较高者、有痴呆家族史者、淀粉样蛋白阳性者),尽快建立全方位和个体化的最优AD预防策略。

原始出处:

Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, Pan A, Zhang C, Jia J, Feng L, Kua EH, Wang YJ, Wang HF, Tan MS, Li JQ, Hou XH, Wan Y, Tan L, Mok V, Tan L, Dong Q, Touchon J, Gauthier S, Aisen PS, Vellas B. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials.J Neurol Neurosurg Psychiatry. 2020 Jul 20:jnnp-2019-321913. doi: 10.1136/jnnp-2019-321913

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-28 xjy04
  5. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 dudu2015

    期待进一步系统的关于认知功能障碍的研究

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 14818eb4m67暂无昵称

    学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 ms7000000689223974

    相关资讯请继续分享,谢谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 ms7000000689223974

    很好很详细,谢谢分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1818047, encodeId=8526181804e56, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 30 09:55:47 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709177, encodeId=2d1b1e09177f9, content=<a href='/topic/show?id=40db41118ff' target=_blank style='color:#2F92EE;'>#国际指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41118, encryptionId=40db41118ff, topicName=国际指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765a31606508, createdName=12498a1cm77暂无昵称, createdTime=Mon May 31 13:55:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817024, encodeId=d355181e0249d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Mon May 17 02:55:47 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449802, encodeId=77331449802b9, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470401, encodeId=3e3314e040171, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Fri Aug 28 06:55:47 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814301, encodeId=08c8814301f6, content=期待进一步系统的关于认知功能障碍的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b61612809, createdName=dudu2015, createdTime=Thu Aug 27 21:32:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814014, encodeId=c3e981401498, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 12:24:27 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813951, encodeId=e219813951ae, content=相关资讯请继续分享,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:13:48 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813893, encodeId=221d813893c1, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:03:39 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813458, encodeId=d13e81345874, content=“脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望<a href='/topic/show?id=54068020409' target=_blank style='color:#2F92EE;'>#老年痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80204, encryptionId=54068020409, topicName=老年痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Wed Aug 26 16:16:41 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-26 Psycho.Dr Du

    “脑计划”目前在全球各地开花,希望能加快AD的研究,为更多人带来希望#老年痴呆症#

    0

相关资讯

Clin Neurophysiol:新型敏感的脑电图测量可用于用于阿尔茨海默病的功能连接

在阿尔茨海默病(AD)的临床试验中,功能连接受损(FC)的改善可以为该药物的潜在疗效提供生物学支持。SAPHIR试验的脑电图(EEG)分析显示,治疗可改善总体相对theta功率,但不能通过相滞后指数(

JAMA:血浆P-tau217水平是鉴别阿尔茨海默病的重要生物标志物

研究认为,血浆P-tau217是区分阿尔茨海默病与他神经退行性疾病的有效临床手段

Alzheimers Dement :一种生物标志物的发现,可提前预测阿尔茨海默病

阿尔茨海默病(AD)是最常见的痴呆类型,是全球65岁以上老人致残的主要原因。因此,AD迫切需要有效的治疗方法。然而,在认知障碍发作后治疗AD的临床试验面临巨大挑战。

Alzheimers Dement: 贾建平团队发现生物标志物,可提前5年至7年预测阿尔茨海默病!

阿尔茨海默病已成为严重危害全球老年人健康和生活质量的疾病之一,记者日前从首都医科大学宣武医院获悉,该院贾建平教授团队研究发现可在症状出现前5年至7年预测阿尔茨海默病的生物标志物。

AlzData——阿尔茨海默病前沿数据库

AlzData,阿尔茨海默病最前沿数据库

J Clin Psychiatry:早期使用抗精神病药物改善症状可预测AD患者神经精神症状的后续治疗反应

本研究旨在利用干预有效性临床抗精神病试验-阿尔茨海默病(CATIE-AD)的数据集,确定个别症状的早期改善有助于随后对抗精神病药物治疗阿尔茨海默病(AD)患者神经精神症状(NPSs)的治疗反应。

Baidu
map
Baidu
map
Baidu
map